Company Long-Term Loans and Borrowings: Protagonist Therapeutics Inc (PTGX)
A stable humanitarian status shields the business of Protagonist Therapeutics (PTGX) from trade conflicts, while 0.01 is recorded as the baseline value. The company's long-term debt level demonstrates current financial stability. Growth relies on the commercialization of peptide technologies and capturing the polycythemia treatment niche, while operational flexibility is achieved through the outsourcing of drug production and logistics.
Protagonist Therapeutics Inc (PTGX) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Protagonist Therapeutics|PTGX - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Protagonist Corp|PTGX - Company Debts|Debt to Book Value Protagonist Therapeutics|PTGX - Company Long-Term Debt|Company Current Liabilities Protagonist Therapeutics|Quick Ratio protagonist-inc.com
- earnings and multiples data:
Analysis of all company metrics:PTGX - protagonist-inc.com
Assessing operational resilience requires an analysis of the issuer's long-term liabilities, which measure the total volume of loans with maturities exceeding one year to evaluate systemic financial pressure. For Protagonist Therapeutics (PTGX), which possesses significant liquidity reserves and payments from J&J, the low dynamics of this metric confirm the autonomy of peptide drug development without the risk of cash flow gaps.
Competitors of Protagonist Therapeutics (PTGX)
Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Immunovant Therapeutics|KNSA (Kiniksa Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts grifols.com|Company Long-Term Liabilities ADPT (Adaptive Biotechnologies Corporation)|CLDX (Celldex Therapeutics Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts AUPH (Aurinia Pharma)|Long-Term Debt Volume BioCryst Corp (BCRX)|VERA - Company Long-Term Debt|dianthustx.com (DNTH) - Company Long-Term Liabilities|Pharvaris (PHVS) - Company Long-Term Debt|Company Long-Term Liabilities AbCellera Bio|Company Long-Term Liabilities TRML|Company Long-Term Debts Precigen Corp|Company Long-Term Debt Pharming Group N.V. (PHAR)|nektar.com - Company Long-Term Indebtedness|Company Long-Term Debts UPB (Upstream Bio)|Zenas Bio (ZBIO) - Long-Term Debt|IMNM - Company Long-Term Debt|Long-Term Liabilities GOSS|KalVista Pharmaceuticals (KALV) - Company Long-Term Debt|septerna.com - Company Long-Term Loans and Borrowings|Company Long-Term Debt Pieris Pharmaceuticals, Inc.|Long-Term Debt Savara Inc SVRA|Company Long-Term Liabilities RIGL (Rigel Pharmaceuticals Inc)|Amount of Long-Term Liabilities ANAB|Company Long-Term Debts ATXS (Astria Therapeutics)|Company Long-Term Debts engene.com ENGN|RAPT Therapeutics, Inc. - Company Long-Term Debts|Long-Term Indebtedness Aerovate Therapeutics Inc (JBIO)|Aclaris (ACRS) - Company Long-Term Debt|Long-Term Debt Kyverna Therapeutics, Inc (KYTX)|Company Long-Term Debt Tiziana Life Sciences|Company Long-Term Indebtedness CABA (cabalettabio.com)|Company Long-Term Debts VTYX|Long-Term Debt Volume Theratechnologies, Inc.|Company Long-Term Debt Avalo Therapeutics Inc. AVTX|Long-Term Debt Volume Eledon Pharmaceuticals, Inc (ELDN)|AGEN: Company Long-Term Liabilities|climbbio.com - Amount of Long-Term Liabilities|ZURA (Zura Bio Limited) - Company Long-Term Liabilities|aTyr Pharma Inc - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities ADAG|IMA (Ikena Oncology, Inc.) - Amount of Long-Term Liabilities|Company Long-Term Debts STTK|EQ (equilliumbio.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CNTB (Connect Biopharma Holdings Limited)|Immunic Therapeutics (IMUX) - Long-Term Debt|ATRA - Company Long-Term Debt|Company Long-Term Loans and Borrowings IFRX (InflaRx N.V.)|XFOR: Company Long-Term Debts|Adicet Bio, Inc. (ACET) - Company Long-Term Debts|Company Long-Term Debt Celularity Inc|INmune Bio Inc - Long-Term Liabilities|Company Long-Term Debts BRNS|KZR - Long-Term Debt|SAB Biotherapeutics - Company Long-Term Liabilities|Company Long-Term Debts akaritx.com AKTX|ENLV: Company Long-Term Liabilities|Q32 Bio Inc. - Amount of Long-Term Liabilities|GOVX: Company Long-Term Debts|EDSA - Long-Term Debt Volume|IBIO (iBio, Inc.) - Company Long-Term Debts|Company Long-Term Liabilities Carisma Tx (CARM)|Company Long-Term Debt XTL Biopharmaceuticals Ltd. (XTLB)|Long-Term Debt Volume boltbio.com|Company Long-Term Debt HCW Biologics HCWB|APVO (Aptevo Therapeutics, Inc.) - Long-Term Liabilities|AIM: Company Long-Term Liabilities|Aditxt - Amount of Long-Term Liabilities|GRI: Company Long-Term Debts|Long-Term Indebtedness XORTX Therapeutics Inc XRTX|Company Long-Term Liabilities HIND|Company Long-Term Indebtedness REVB (Revelation Biosciences Corp)|Company Long-Term Debt Indaptus Therapeutics (INDP)|SCNI: Long-Term Liabilities|Company Long-Term Debts CALI (CalciMedica)|Company Long-Term Loans and Borrowings AFMD|Allakos Therapeutics - Company Long-Term Debts|HOOK - Company Long-Term Debts|igmbio.com (IGMS) - Company Long-Term Debt|iteostherapeutics.com - Company Long-Term Loans and Borrowings|Company Long-Term Debt Ocean Biomedical|Company Long-Term Liabilities TC BioPharm (Holdings) Plc (TCBP)|Company Long-Term Debts THRD